127 related articles for article (PubMed ID: 8740008)
1. Inhibition of the monocyte chemiluminescent response to anti-D-sensitized red cells by Fc gamma RI-blocking antibodies which ameliorate the severity of haemolytic disease of the newborn.
Shepard SL; Noble AL; Filbey D; Hadley AG
Vox Sang; 1996; 70(3):157-63. PubMed ID: 8740008
[TBL] [Abstract][Full Text] [Related]
2. The functional activity of human monocytes passively sensitized with monoclonal anti-D suggests a novel role for Fc gamma RI in the immune destruction of blood cells.
Griffiths HL; Kumpel BM; Elson CJ; Hadley AG
Immunology; 1994 Nov; 83(3):370-7. PubMed ID: 7835961
[TBL] [Abstract][Full Text] [Related]
3. The use of interferon-gamma-treated U937 cells in chemiluminescence assays to detect red cell, platelet and granulocyte antibodies of potential clinical significance.
Hadley AG; Poole GD; Amphlett NW; Lucas GF
Clin Lab Haematol; 1992; 14(4):315-26. PubMed ID: 1478011
[TBL] [Abstract][Full Text] [Related]
4. Monocyte-bound monoclonal antibodies inhibit the Fc gamma RI-mediated phagocytosis of sensitized red cells: the efficiency and mechanism of inhibition are determined by the nature of the antigen.
Shepard SL; Hadley AG
Immunology; 1997 Feb; 90(2):314-22. PubMed ID: 9135563
[TBL] [Abstract][Full Text] [Related]
5. Section 1C: Assessment of the functional activity and IgG Fc receptor utilisation of 64 IgG Rh monoclonal antibodies. Coordinator's report.
Kumpel BM; Beliard R; Brossard Y; Edelman L; de Haas M; Jackson DJ; Kooyman P; Ligthart PC; Monchâtre E; Overbeeke MA; Puillandre P; de Romeuf C; Wilkes AM
Transfus Clin Biol; 2002 Jan; 9(1):45-53. PubMed ID: 11889899
[TBL] [Abstract][Full Text] [Related]
6. The role of Rh antibodies in haemolytic disease of the newborn.
Hadley AG; Kumpel BM
Baillieres Clin Haematol; 1993 Jun; 6(2):423-44. PubMed ID: 8043933
[TBL] [Abstract][Full Text] [Related]
7. The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-Rh(D) antibodies.
Hadley AG; Kumpel BM; Merry AH
Clin Lab Haematol; 1988; 10(4):377-84. PubMed ID: 3150696
[TBL] [Abstract][Full Text] [Related]
8. A major role of class I Fc gamma receptors in immunoglobulin G anti-D-mediated red blood cell destruction by fetal mononuclear phagocytes.
Wiener E; Mawas F; Dellow RA; Singh I; Rodeck CH
Obstet Gynecol; 1995 Aug; 86(2):157-62. PubMed ID: 7617343
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the protective effect of maternal FcR-blocking IgG alloantibodies HLA-DR in Rh D-haemolytic disease of the newborn.
Dooren MC; van Kamp IL; Kanhai HH; Gravenhorst JB; von dem Borne AE; Engelfriet CP
Vox Sang; 1993; 65(1):55-8. PubMed ID: 8362515
[TBL] [Abstract][Full Text] [Related]
10. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR).
Dooren MC; Kuijpers RW; Joekes EC; Huiskes E; Goldschmeding R; Overbeeke MA; von dem Borne AE; Engelfriet CP; Ouwehand WH
Lancet; 1992 May; 339(8801):1067-70. PubMed ID: 1349101
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody to the type II Fc receptor for human IgG blocks potentiation of monocyte and neutrophil IgG-induced respiratory burst activation by aggregated C-reactive protein.
Zeller JM; Sullivan BL
Cell Immunol; 1993 Jun; 149(1):144-54. PubMed ID: 8513509
[TBL] [Abstract][Full Text] [Related]
12. Role of Fc gamma RIIa (CD32) in IgG anti-RhD-mediated red cell phagocytosis in vitro.
Wiener E; Dellow RA; Mawas F; Rodeck CH
Transfus Med; 1996 Sep; 6(3):235-41. PubMed ID: 8885153
[TBL] [Abstract][Full Text] [Related]
13. A comparison of in vitro tests for predicting the severity of haemolytic disease of the fetus and newborn.
Hadley AG
Vox Sang; 1998; 74 Suppl 2():375-83. PubMed ID: 9704470
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to human major histocompatibility complex products inhibit Fc gamma receptors types I and II.
Neppert J; Jungi TW
Transfus Med; 1996 Jun; 6(2):125-31. PubMed ID: 8809960
[TBL] [Abstract][Full Text] [Related]
15. Quantitative and functional asessment of anti-RhD: a comparative study of non-invasive methods in antenatal prediction of Rh hemolytic disease.
Filbey D; Garner SF; Hadley AG; Shepard SL
Acta Obstet Gynecol Scand; 1996 Feb; 75(2):102-7. PubMed ID: 8604593
[TBL] [Abstract][Full Text] [Related]
16. Human monocyte-mediated cytotoxicity towards erythrocytes induced by hybrid mouse monoclonal antibodies: effect of antibody binding valency on IgG-Fc gamma R interaction.
Koolwijk P; Van de Winkel JG; Otten I; Bast BJ
Immunology; 1992 Feb; 75(2):336-42. PubMed ID: 1532380
[TBL] [Abstract][Full Text] [Related]
17. Laboratory assays for predicting the severity of haemolytic disease of the fetus and newborn.
Hadley AG
Transpl Immunol; 2002 Aug; 10(2-3):191-8. PubMed ID: 12216949
[TBL] [Abstract][Full Text] [Related]
18. Activity of two types of Fc receptors, Fc gamma RI and Fc gamma RII, in human monocyte cytotoxicity to sensitized erythrocytes.
van de Winkel JG; Boonen GJ; Janssen PL; Vlug A; Hogg N; Tax WJ
Scand J Immunol; 1989 Jan; 29(1):23-31. PubMed ID: 2522235
[TBL] [Abstract][Full Text] [Related]
19. Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn.
Hadley AG; Kumpel BM; Leader KA; Poole GD; Fraser ID
Br J Haematol; 1991 Feb; 77(2):221-8. PubMed ID: 2004024
[TBL] [Abstract][Full Text] [Related]
20. Functional interactions of red cells sensitized by IgG1 and IgG3 human monoclonal anti-D with enzyme-modified human monocytes and FcR-bearing cell lines.
Kumpel BM; Hadley AG
Mol Immunol; 1990 Mar; 27(3):247-56. PubMed ID: 2111455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
